Page last updated: 2024-08-21

hematoporphyrin and Angiomatosis Oculoorbital-Thalamic Syndrome

hematoporphyrin has been researched along with Angiomatosis Oculoorbital-Thalamic Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Diao, P; Han, C; Jiang, X; Li, X; Liu, L; Yang, Y; Zhou, H1
Hao, D; Jiang, X; Li, E; Liu, L1

Other Studies

2 other study(ies) available for hematoporphyrin and Angiomatosis Oculoorbital-Thalamic Syndrome

ArticleYear
Hematoporphyrin monomethyl ether photodynamic therapy for the treatment of Sturge-Weber syndrome and large segmental facial port-wine stain.
    Dermatologic therapy, 2022, Volume: 35, Issue:5

    Topics: Hematoporphyrins; Humans; Photochemotherapy; Port-Wine Stain; Sturge-Weber Syndrome

2022
A rare case of Klippel-Trenaunay syndrome in association with Sturge-Weber syndrome treated by HMME-PDT.
    Photodermatology, photoimmunology & photomedicine, 2020, Volume: 36, Issue:6

    Topics: Adult; Face; Hematoporphyrins; Humans; Klippel-Trenaunay-Weber Syndrome; Male; Photosensitizing Agents; Port-Wine Stain; Sturge-Weber Syndrome

2020